Carglumic acid in methylmalonic acidemia: Use of breast milk as an alternative vehicle to water
- 27 May 2022
- journal article
- research article
- Published by Wiley in Journal of Clinical Pharmacy and Therapeutics
- Vol. 47 (9) , 1475-1477
Abstract
Carbaglu® or N-carbamylglutamate (NCG) is not recommended for administration in a vehicle other than water. We aim to report the use of breast milk (BM) as an alternative vehicle in a neonate rejecting NCG diluted in water. A neonate diagnosed with methylmalonic acidemia presented symptomatology of acidemia and hyperammonemia. After the patient refused oral NCG administration, a dissolution test was conducted in BM showing correct dissolution. The NCG-BM solution was tolerated and plasma ammonium concentrations remained within range in subsequent analytical controls. BM as a vehicle for NCG is a safe and effective option for patients who refuse suspension in water and could lead to better treatment compliance in paediatric patients.Keywords
This publication has 6 references indexed in Scilit:
- DDIEM: drug database for inborn errors of metabolismOrphanet Journal of Rare Diseases, 2020
- Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapyNature Reviews Nephrology, 2020
- Pathophysiology of propionic and methylmalonic acidemias. Part 1: ComplicationsJournal of Inherited Metabolic Disease, 2019
- Suggested guidelines for the diagnosis and management of urea cycle disorders: First revisionJournal of Inherited Metabolic Disease, 2019
- The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentationJournal of Inherited Metabolic Disease, 2015
- Food Drug InteractionsOman Medical Journal, 2011